The 340B drug pricing program was established to help safety-net providers like Federally Qualified Health Centers (FQHCs) and hospitals that support rural populations stretch scarce federal resources to provide more comprehensive services and reach more eligible patients in rural and underserved areas. The program requires pharmaceutical manufacturers to sell certain outpatient drugs to safety-net providers at a discount who then re-invest these savings into patient services and charity care. Drug companies – not taxpayers nor the government – cover the cost of this program.